Cardiac autonomic tone, plasma BDNF levels and paroxetine response in newly diagnosed patients of generalised anxiety disorder

References

• Bakhla AK, Verma V, Hembram M, Praharaj SK, Sinha VK. 2013. Internal consistency and factor structure of 12-item general health questionnaire in visually impaired students. Ind Psychiatry J. 22(2):109–113. doi:10.4103/0972-6748.132918
   PubMedGoogle Scholar
• Ball S, Marangell LB, Lipsius S, Russell JM. 2013. Brain-derived neurotrophic factor in generalized anxiety disorder: results from a duloxetine clinical trial. Prog Neuropsychopharmacol Biol Psychiatry. 43:217–221. doi:10.1016/j.pnpbp.2013.01.002
   PubMed Web of Science ®Google Scholar
• Bandelow B, Baldwin D, Abelli M, Bolea-Alamanac B, Bourin M, Chamberlain SR, Cinosi E, Davies S, Domschke K, Fineberg N, et al. 2017. Biological markers for anxiety disorders, OCD and PTSD: a consensus statement. Part II: neurochemistry, neurophysiology and neurocognition. World J Biol Psychiatry. 18(3):162–214. doi:10.1080/15622975.2016.1190867
   PubMed Web of Science ®Google Scholar
• Bus BAA, Molendijk ML, Penninx BJWH, Buitelaar JK, Kenis G, Prickaerts J, Elzinga BM, Voshaar RCO. 2011. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology. 36(2):228–239. doi:10.1016/j.psyneuen.2010.07.013
   PubMed Web of Science ®Google Scholar
• Bus BA, Molendijk ML, Tendolkar I, Penninx BW, Prickaerts J, Elzinga BM, Voshaar RC. 2015. Chronic depression is associated with a pronounced decrease in serum brain-derived neurotrophic factor over time. Mol Psychiatry. 20(5):602–608. doi:10.1038/mp.2014.83
   PubMed Web of Science ®Google Scholar
• Calabrese F, Molteni R, Cattaneo A, Macchi F, Racagni G, Gennarelli M, Ellenbroek BA, Riva MA. 2010. Long-term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms. Mol Pharmacol. 77(5):846–853. doi:10.1124/mol.109.063081
   PubMed Web of Science ®Google Scholar
• Carbone DL, Handa RJ. 2013. Sex and stress hormone influences on the expression and activity of brain-derived neurotrophic factor. Neurosci. 239:295–303. doi:10.1016/j.neuroscience.2012.10.073
   PubMed Web of Science ®Google Scholar
• Carlino D, Francavilla R, Baj G, Kulak K, d’Adamo P, Ulivi S, Cappellani S, Gasparini P, Tongiorgi E. 2015. Brain-derived neurotrophic factor serum levels in genetically isolated populations: gender-specific association with anxiety disorder subtypes but not with anxiety levels or Val66Met polymorphism. Peer J. 3:e1252–26539329. doi:10.7717/peerj.1252
   PubMed Web of Science ®Google Scholar
• Chalmers JA, Quintana DS, Abbott M-A, Kemp AH. 2014. Anxiety disorders are associated with reduced heart rate variability: a meta-analysis. Front Psychiatry. 5:80. doi:10.3389/fpsyt.2014.00080
   PubMed Web of Science ®Google Scholar
• Chang HA, Chang CC, Tzeng NS, Kuo TBJ, Lu RB, Huang SY. 2013. Generalized anxiety Disorder, comorbid major depression and heart rate variability: a case-control study in Taiwan. Psychiatry Investig. 10(4):326–335. doi:10.4306/pi.2013.10.4.326
   PubMed Web of Science ®Google Scholar
• Duman RS, Monteggia LM. 2006. A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 59(12):1116–1127. doi:10.1016/j.biopsych.2006.02.013
   PubMed Web of Science ®Google Scholar
• Friedman BH. 2007. An autonomic flexibility-neurovisceral integration model of anxiety and cardiac vagal tone. Biol Psychol. 74(2):185–199. doi:10.1016/j.biopsycho.2005.08.009
   PubMed Web of Science ®Google Scholar
• Golderberg D, Williams P. 1988. A user’s guide to the General Health questionnaire. Windsor, UK: NFER-Nelson.
   Google Scholar
• Guy W, editor. 1976. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration.
   Google Scholar
• Hamilton M. 1959. The assessment of anxiety states by rating. Br J Med Psychol. 32(1):50–55. doi:10.1111/j.2044-8341.1959.tb00467.x
   PubMed Web of Science ®Google Scholar
• Hammel JC, Smitherman TA, McGlynn FD, Mulfinger AMM, Lazarte AA, Gothard KD. 2011. Vagal influence during worry and cognitive challenge. Anxiety Stress Coping. 24(2):121–136. doi:10.1080/10615806.2010.490912
   PubMed Web of Science ®Google Scholar
• Janszky I, Ahnve S, Lundberg I, Hemmingsson T. 2010. Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. J Am Coll Cardiol. 56(1):31–37. doi:10.1016/j.jacc.2010.03.033
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. 2005. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 62(6):593–602. doi:10.1001/archpsyc.62.6.593
   PubMed Web of Science ®Google Scholar
• Kim K, Lee S, Kim JH. 2016. Diminished autonomic neurocardiac function in patients with generalized anxiety disorder. NDT. 12:3111–3118. doi:10.2147/NDT.S121533
   Google Scholar
• Kollai M, Kollai B. 1992. Cardiac vagal tone in generalised anxiety disorder. Br J Psychiatry. 161(6):831–835. doi:10.1192/bjp.161.6.831
   PubMedGoogle Scholar
• Licht CM, de Geus EJ, van Dyck R, Penninx BW. 2009. Association between anxiety disorders and heart rate variability in the Netherlands study of depression and anxiety (NESDA). Psychosom Med. 71(5):508–518. doi:10.1097/PSY.0b013e3181a292a6
   PubMed Web of Science ®Google Scholar
• Lyonfields JD, Borkovec TD, Thayer JF. 1995. Vagal tone in generalized anxiety disorder and the effects of aversive imagery and worrisome thinking. Behav Ther. 26(3):457–466. doi:10.1016/S0005-7894(05)80094-2
   Web of Science ®Google Scholar
• Molendijk ML, Bus BAA, Spinhoven P, Penninx BWJH, Kenis G, Prickaerts J, Voshaar RO, Elzinga BM. 2011. Serum levels of brain-derived neurotrophic factor in major depressive disorder: State-trait issues, clinical features and pharmacological treatment. Mol Psychiatry. 16(11):1088–1095. doi:10.1038/mp.2010.98
   PubMed Web of Science ®Google Scholar
• Molendijk ML, Bus BAA, Spinhoven P, Penninx BWJH, Prickaerts J, Oude Voshaar RC, Elzinga BM. 2012. Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety. World J Biol Psychiatry. 13(7):535–543. doi:10.3109/15622975.2011.587892
   PubMed Web of Science ®Google Scholar
• Newman M, et al. 2013. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association.
   Google Scholar
• Ouakinin SR. 2016. Anxiety as a risk factor for cardiovascular diseases. Front Psychiatry. 7:25. doi:10.3389/fpsyt.2016.00025
   PubMed Web of Science ®Google Scholar
• Pallanti S, Tofani T, Zanardelli M, Di Cesare Mannelli L, Ghelardini C. 2014. BDNF and Artemin are increased in drug-naïve non-depressed GAD patients: preliminary data. Int J Psychiatry Clin Pract. 18(4):255–60. doi:10.3109/13651501.2014.940051
   PubMed Web of Science ®Google Scholar
• Pittig A, Arch JJ, Lam CWR, Craske MG. 2013. Heart rate and heart rate variability in panic, social anxiety, obsessive-compulsive, and generalized anxiety disorders at baseline and in response to relaxation and hyperventilation. Int J Psychophysiol. 87(1):19–27. doi:10.1016/j.ijpsycho.2012.10.012
   PubMed Web of Science ®Google Scholar
• Ranjbar F, Akbarzadeh F, Zakeri F, Farahbakhsh M, Ali Nazari M. 2015. citalopram on heart rate variability in women with generalized anxiety disorder. ARYA Atheroscler. 11(3):196–203.
   PubMed Web of Science ®Google Scholar
• Remes O, Brayne C, van der Linde R, Lafortune L. 2016. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain Behav. 6(7):e00497–27458547. doi:10.1002/brb3.497
   PubMed Web of Science ®Google Scholar
• Roest AM, Martens EJ, de Jonge P, Denollet J. 2010. Anxiety and risk of incident coronary heart disease. J Am Coll Cardiol. 56(1):38–46. doi:10.1016/j.jacc.2010.03.034
   PubMed Web of Science ®Google Scholar
• Shinba T. 2017. Major depressive disorder and generalized anxiety disorder show different autonomic dysregulations revealed by heart-rate variability analysis in first-onset drug-naïve patients without comorbidity. Psychiatry Clin Neurosci. 71(2):135–145. doi:10.1111/pcn.12494
   PubMed Web of Science ®Google Scholar
• Smith MA, Makino S, Kvetnansky R, Post RM. 1995. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci. 15(3):1768–1777. doi:10.1523/JNEUROSCI.15-03-01768.1995
   PubMed Web of Science ®Google Scholar
• Suliman S, Hemmings SMJ, Seedat S. 2013. Brain-Derived Neurotrophic Factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis. Front Integr Neurosci. 7:55. doi:10.3389/fnint.2013.00055
   PubMedGoogle Scholar
• Sztajzel J. 2004. Heart rate variability: a noninvasive electrocardiographic method to measure the autonomic nervous system. Swiss Med Wkly. 134(35–36):514–522.
   PubMed Web of Science ®Google Scholar
• Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. 1996. Circulation. 93(5):1043–1065. doi:10.1161/01.CIR.93.5.1043
   PubMed Web of Science ®Google Scholar
• Thayer JF. 2007. What the heart says to the brain (and vice versa) and why we should listen. Psychol Top. 16:241–250.
   Google Scholar
• Thayer JF, Friedman BH, Borkovec TD. 1996. Automatic characteristics of generalized anxiety disorder and worry. Biol Psychiatry. 39(4):255–266. doi:10.1016/0006-3223(95)00136-0
   PubMed Web of Science ®Google Scholar
• van Zyl LT, Hasegawa T, Nagata K. 2008. Effects of antidepressant treatment on heart rate variability in major depression: A quantitative review. Biopsychosoc Med. 2:12. doi:10.1186/1751-0759-2-12
   PubMedGoogle Scholar
• Rg W, Manual A. 2003. Clinical Global Impression (CGI). Assessment. 1:125–126.
   Google Scholar
• Wang Y, Zhang H, Li Y, Wang Z, Fan Q, Yu S, Lin Z, Xiao Z. 2015. BDNF Val66Met polymorphism and plasma levels in Chinese Han population with obsessive-compulsive disorder and generalized anxiety disorder. J Affect Disord. 186:7–12. doi:10.1016/j.jad.2015.07.023
   PubMed Web of Science ®Google Scholar